{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:03:25Z","timestamp":1788822205189,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Science and Technology (DST)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.vaccine.2011.03.082","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T10:40:58Z","timestamp":1303209658000},"page":"4521-4533","source":"Crossref","is-referenced-by-count":35,"title":["A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax"],"prefix":"10.1016","volume":"29","author":[{"given":"Jyotsna","family":"Gorantala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Rahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Krishna","family":"Jayadev Magani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.03.082_bib0005","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0010","first-page":"690","article-title":"The decontamination of Gruinard Island","volume":"4","author":"Manchee","year":"1988","journal-title":"Chem Br"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0015","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/es048705e","article-title":"Degradation of biological weapons agents in the environment: implications for terrorism response","volume":"39","author":"Stuart","year":"2005","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0020","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0025","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"Mock","year":"2001","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142728","article-title":"Anthrax toxin: receptor binding, internalization, pore formation, and translocation","volume":"76","author":"Young","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0035","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase\u2013kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0040","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0045","first-page":"33","article-title":"Anthrax vaccines","volume":"271","author":"Friedlander","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-9433-4-4","article-title":"Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin","volume":"4","author":"Wang","year":"2005","journal-title":"Med Immunol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0055","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0060","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"Fellows","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0065","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0264-410X(01)00387-5","article-title":"Anthrax vaccine: short-term safety experience in humans","volume":"20","author":"Pittman","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0070","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ni0504-460","article-title":"Vaccine development strategies for improving immunization: the role of modern immunology","volume":"5","author":"Levine","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0075","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","article-title":"In vitro correlate of immunity in an animal model of inhalational anthrax","volume":"87","author":"Pitt","year":"1999","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0080","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1128\/IAI.73.9.5978-5987.2005","article-title":"Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0085","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1128\/IAI.72.6.3276-3283.2004","article-title":"Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages","volume":"72","author":"Mohamed","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0090","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1128\/IAI.00884-07","article-title":"Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen","volume":"75","author":"Brahmbhatt","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0095","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2105\/AJPH.2006.102749","article-title":"Anthrax vaccine and public health policy","volume":"97","author":"Weiss","year":"2007","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0100","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0105","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02763","article-title":"Crystal structure of a complex between anthrax toxin and its host cell receptor","volume":"430","author":"Santelli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0110","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/IAI.01722-07","article-title":"Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant","volume":"76","author":"Park","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0115","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.molimm.2008.12.031","article-title":"Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis","volume":"46","author":"Kaur","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0120","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/IAI.68.4.1781-1786.2000","article-title":"Role of toxin functional domains in anthrax pathogenesis","volume":"68","author":"Brossier","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.mt.6300034","article-title":"Adenovirus-based prime-boost immunization for rapid vaccination against anthrax","volume":"15","author":"McConnell","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pbi.2004.01.007","article-title":"Plant-based production of biopharmaceuticals","volume":"7","author":"Fischer","year":"2004","journal-title":"Curr Opin Plant Biol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.embor.7400470","article-title":"Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants","volume":"6","author":"Ma","year":"2005","journal-title":"EMBO Rep"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0140","first-page":"365","article-title":"Engineering the chloroplast genome for hyperexpression of human therapeutic proteins and vaccine antigens","volume":"267","author":"Kumar","year":"2004","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/83559","article-title":"Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals","volume":"19","author":"De Cosa","year":"2001","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0150","first-page":"33","article-title":"Chloroplast-derived vaccine antigens and biopharmaceuticals: expression, folding, assembly and functionality","volume":"332","author":"Chebolu","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0155","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1096\/fj.05-5134fje","article-title":"Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system","volume":"20","author":"Limaye","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0160","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1006\/jmbi.2001.4921","article-title":"Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts","volume":"311","author":"Daniell","year":"2001","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0165","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/nar\/gkg221","article-title":"Expression of tetanus toxin fragment C in tobacco chloroplasts","volume":"31","author":"Tregoning","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0170","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1016\/j.vaccine.2004.01.069","article-title":"Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food\/feed crop","volume":"22","author":"Watson","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0175","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1096\/fj.04-3215fje","article-title":"Transformation of an edible crop with the pagA gene of Bacillus anthracis","volume":"19","author":"Aziz","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0180","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/IAI.00050-08","article-title":"Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts","volume":"76","author":"Arlen","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1467-7652.2004.00057.x","article-title":"High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts","volume":"2","author":"Molina","year":"2004","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0190","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00425-009-0898-2","article-title":"High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts","volume":"229","author":"Scotti","year":"2009","journal-title":"Planta"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1467-7652.2009.00479.x","article-title":"Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery","volume":"8","author":"Davoodi-Semiromi","year":"2010","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-291X(02)02625-6","article-title":"Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax","volume":"299","author":"Aziz","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0205","first-page":"13","article-title":"Isolation of plant DNA from fresh tissue","volume":"12","author":"Doyle","year":"1990","journal-title":"Focus"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0210","first-page":"265","article-title":"A sporulation medium for Bacillus anthracis","volume":"37","author":"Kim","year":"1974","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0215","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1073\/pnas.0502159102","article-title":"Anthrax lethal factor inhibition","volume":"102","author":"Shoop","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0220","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/nar\/29.4.970","article-title":"Complementarity of the 16S rRNA penultimate stem with sequences downstream of the AUG destabilizes the plastid mRNAs","volume":"29","author":"Kuroda","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0225","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2672.1999.00901.x","article-title":"Presentation of protective antigen to the mouse immune system: immune sequelae","volume":"87","author":"Williamson","year":"1999","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0230","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1128\/IAI.73.12.8266-8274.2005","article-title":"Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge","volume":"73","author":"Koya","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0235","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/IAI.73.6.3408-3414.2005","article-title":"Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines","volume":"73","author":"Aulinger","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0240","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009","volume":"59","author":"Wright","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0245","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3201\/eid0810.020349","article-title":"Antimicrobial post-exposure prophylaxis for anthrax: adverse events and adherence","volume":"8","author":"Shepard","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0250","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1128\/CVI.00173-09","article-title":"Recombinant Sindbis virus vectors designed to express protective antigen of Bacillus anthracis protect animals from anthrax and display synergy with ciprofloxicin","volume":"11","author":"Thomas","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0255","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1359-6446(03)02706-5","article-title":"Spinach makes a safer anthrax vaccine","volume":"8","author":"Sussman","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0260","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1016\/j.vaccine.2007.01.068","article-title":"Immunogenicity of a subunit vaccine against Bacillus anthracis","volume":"25","author":"Chichester","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0265","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/08820131003622635","article-title":"Secretory IgA: arresting microbial pathogens at epithelial borders","volume":"39","author":"Mantis","year":"2010","journal-title":"Immunol Invest"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0270","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2672.1999.00900.x","article-title":"Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax","volume":"87","author":"Zegers","year":"1999","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0275","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/S0264-410X(02)00207-4","article-title":"Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin","volume":"20","author":"Gaur","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0280","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0285","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1128\/IAI.72.2.1181-1183.2004","article-title":"Needle-free skin patch vaccination method for anthrax","volume":"72","author":"Matyas","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0290","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1016\/j.vaccine.2007.01.075","article-title":"Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine","volume":"25","author":"Zeng","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0295","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1128\/IAI.72.12.7096-7106.2004","article-title":"Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA","volume":"72","author":"Galen","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0300","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/IAI.01242-06","article-title":"Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis","volume":"75","author":"Stokes","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0305","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The immune geography of IgA induction and function","volume":"1","author":"Macpherson","year":"2008","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0310","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1073\/pnas.191617598","article-title":"Oral immunization with hepatitis B surface antigen expressed in transgenic plants","volume":"98","author":"Kong","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0315","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1467-7652.2006.00191.x","article-title":"Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein","volume":"4","author":"Zhang","year":"2006","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0320","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1023\/A:1020393426750","article-title":"A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT)","volume":"11","author":"Chikwamba","year":"2002","journal-title":"Transgenic Res"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0325","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0330","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants \u2013 a classification and review of their modes of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0335","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","article-title":"Aluminium adjuvants \u2013 in retrospect and prospect","volume":"22","author":"Lindblad","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0340","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4049\/jimmunol.162.1.114","article-title":"Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin","volume":"162","author":"Marinaro","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0345","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0350","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2958.1999.01137.x","article-title":"Germination of Bacillus anthracis spores within alveolar macrophages","volume":"31","author":"Rontani","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0355","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/0022-1317-51-10-821","article-title":"In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody","volume":"51","author":"Welkos","year":"2002","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0360","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0365","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1128\/IAI.72.6.3471-3477.2004","article-title":"Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine","volume":"72","author":"Marcus","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0370","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11103-004-0192-4","article-title":"Generation of fertile transplastomic soybean","volume":"55","author":"Dufourmantel","year":"2004","journal-title":"Plant Mol Biol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0375","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1104\/pp.104.045187","article-title":"Plastid-expressed betaine aldehyde dehydrogenase gene in carrot cultured cells, roots, and leaves confers enhanced salt tolerance","volume":"136","author":"Kumar","year":"2004","journal-title":"Plant Physiol"},{"key":"10.1016\/j.vaccine.2011.03.082_bib0380","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11248-005-3997-2","article-title":"Efficient and stable transformation of Lactuca sativa L. cv. Cisco (lettuce) plastids","volume":"15","author":"Kanamoto","year":"2006","journal-title":"Transgenic Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11004646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11004646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T11:06:00Z","timestamp":1686049560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11004646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":76,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0264410X11004646"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}